NPI: 1790307593 · STIGLER, OK 74462 · Critical Access Hospital · NPI assigned 05/14/2020
Authorized official SINGH, KIRNJOT controls 20+ related entities in our dataset. Read more
| Authorized Official | SINGH, KIRNJOT (PRESIDENT) |
| NPI Enumeration Date | 05/14/2020 |
Other providers sharing the same authorized official: SINGH, KIRNJOT
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 135 | $18K |
| 2021 | 653 | $84K |
| 2022 | 2,368 | $199K |
| 2023 | 3,947 | $204K |
| 2024 | 1,898 | $135K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 873 | 804 | $197K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 1,059 | 1,026 | $167K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 415 | 396 | $147K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 589 | 570 | $22K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 808 | 577 | $19K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 330 | 325 | $18K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 79 | 79 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 629 | 594 | $9K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 89 | 87 | $8K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 342 | 282 | $7K |
| 36415 | Collection of venous blood by venipuncture | 1,097 | 1,069 | $5K |
| 80053 | Comprehensive metabolic panel | 468 | 459 | $4K |
| 87400 | 317 | 306 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 492 | 487 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 52 | 52 | $2K |
| 84481 | 132 | 132 | $2K | |
| 86710 | 179 | 176 | $2K | |
| 99307 | 177 | 174 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | 105 | 105 | $2K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 19 | 19 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | 31 | 30 | $1K |
| 86376 | 117 | 117 | $1K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 17 | 17 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | 121 | 121 | $966.37 |
| 80047 | 65 | 64 | $781.44 | |
| 80061 | Lipid panel | 55 | 55 | $586.51 |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16 | 15 | $565.24 |
| 82652 | 13 | 13 | $411.00 | |
| 83735 | 68 | 68 | $369.45 | |
| 81000 | 24 | 24 | $215.90 | |
| 81001 | 69 | 68 | $197.92 | |
| 85027 | 31 | 30 | $184.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 24 | 24 | $180.49 |
| 87807 | 14 | 14 | $163.10 | |
| 85007 | 31 | 30 | $104.78 | |
| 81025 | 13 | 13 | $99.58 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 14 | 14 | $18.90 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 15 | 15 | $3.56 |
| J3490 | Unclassified drugs | 12 | 12 | $0.00 |